Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 136th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
PBYI	PUMA BIOTECHNOLOGY INC	$504.84M	20.90%	13.30%	24.27%	46.50%	0.39	2.91	74.80%	11.60%	15.00%
PGEN	PRECIGEN INC	$2.88B	-1,063.90%	-211.90%	-104.99%	-77.10%	2.91	4.58	90.70%	-392.80%	-172.64%
ONC	BEONE MEDICINES LTD	$41.57B	14.20%	7.80%	14.29%	27.40%	0.77	3.41	88.90%	10.70%	16.45%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$2.29B	20.10%	14.10%	22.36%	52.00%	0.37	3.48	75.40%	18.90%	26.53%
ICCC	IMMUCELL CORP	$90.28M	2.70%	1.80%	2.02%	1.80%	0.49	4.75	40.30%	2.60%	2.78%
FENC	FENNEC PHARMACEUTICALS INC	$378.73M	-11.70%	-4.90%	-3.47%	-8.50%	0.79	5.85	93.70%	-5.50%	-3.71%
CORT	CORCEPT THERAPEUTICS INC	$12.40B	8.30%	6.40%	0.74%	0.90%	0.26	2.86	98.30%	6.50%	0.65%
HALO	HALOZYME THERAPEUTICS INC	$12.66B	180.60%	16.50%	27.03%	24.60%	16.96	2.71	82.40%	24.90%	36.28%
VCYT	VERACYTE INC	$3.70B	8.60%	8.00%	8.15%	49.40%	0.07	9.16	71.70%	20.40%	20.65%
REGN	REGENERON PHARMACEUTICALS INC	$77.27B	13.80%	10.60%	14.42%	15.10%	0.32	3.34	84.90%	27.90%	33.61%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$3.36B	15.10%	6.50%	13.15%	12.00%	1.22	2.92	91.10%	6.10%	9.30%
PTCT	PTC THERAPEUTICS INC	$5.42B	N/A	-1.30%	4.77%	10.30%	-20.66	3.39	93.00%	-3.80%	11.72%
JAZZ	JAZZ PHARMACEUTICALS PLC	$15.08B	21.40%	8.20%	10.15%	13.40%	1.31	1.78	88.40%	20.40%	19.53%
PTGX	PROTAGONIST THERAPEUTICS INC	$9.12B	12.00%	11.20%	9.94%	17.10%	0.05	21.71	100.00%	29.40%	29.91%
RPRX	ROYALTY PHARMA PLC	$33.48B	8.30%	4.10%	6.13%	4.50%	1.03	2.80	100.00%	32.10%	46.37%
AUPH	AURINIA PHARMACEUTICALS INC	$2.18B	59.00%	44.90%	23.75%	28.20%	0.29	5.42	90.40%	100.80%	52.80%
VCEL	VERICEL CORP	$2.08B	6.90%	5.00%	5.71%	6.20%	0.36	5.04	74.60%	7.90%	8.40%
ZVRA	ZEVRA THERAPEUTICS INC	$673.41M	32.80%	20.50%	29.52%	42.70%	0.39	5.17	95.50%	42.80%	55.12%
EXEL	EXELIXIS INC	$14.53B	42.50%	32.00%	48.56%	49.90%	0.35	3.46	96.50%	35.30%	42.51%
BCRX	BIOCRYST PHARMACEUTICALS INC	$2.11B	N/A	-77.60%	-87.65%	-34.50%	-2.23	2.32	97.80%	-40.90%	-32.52%
BMRN	BIOMARIN PHARMACEUTICAL INC	$11.59B	1.20%	0.80%	2.31%	3.70%	0.85	2.39	76.10%	2.10%	6.83%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$5.91B	13.70%	10.10%	15.76%	24.30%	0.37	3.90	89.80%	9.60%	13.59%
OMER	OMEROS CORP	$1.39B	-109.40%	46.00%	70.76%	25.50%	-6.59	1.95	96.40%	324.90%	353.38%
ORMP	ORAMED PHARMACEUTICALS INC	$195.09M	73.00%	64.20%	32.47%	50.70%	0.16	4.98	N/A	N/A	N/A
XERS	XERIS BIOPHARMA HOLDINGS INC	$1.82B	-426.30%	-4.40%	4.99%	3.70%	-43.32	1.45	86.60%	-5.10%	3.31%
INCY	INCYTE CORP	$24.97B	29.60%	22.60%	30.02%	87.80%	0.24	4.59	92.60%	27.70%	33.85%
FTRE	FORTREA HOLDINGS INC	$1.88B	-15.50%	-3.10%	0.37%	0.50%	4.18	0.96	19.30%	-3.20%	0.24%
RLYB	RALLYBIO CORP	$91.45M	68.60%	64.50%	49.61%	272.20%	0.04	27.27	100.00%	7,051.20%	7,256.19%
CYPH	CYPHERPUNK TECHNOLOGIES INC	$348.08M	-0.90%	-0.90%	0.89%	1.40%	0.03	79.19	N/A	N/A	N/A
PLX	PROTALIX BIOTHERAPEUTICS INC	$216.74M	31.60%	20.10%	31.31%	48.10%	0.55	2.94	69.20%	23.50%	30.66%
ANAB	ANAPTYSBIO INC	$1.51B	2,515.20%	57.40%	5.31%	3.60%	28.95	5.61	100.00%	82.40%	6.30%
APMD	APNIMED INC	$994.98M	N/A	N/A	N/A	N/A	-0.71	5.19	N/A	N/A	N/A
ARGX	ARGENX SE	$60.70B	23.60%	19.90%	20.69%	41.10%	0.19	5.12	90.10%	32.20%	32.85%
ACAD	ACADIA PHARMACEUTICALS INC	$3.48B	32.40%	24.40%	8.79%	13.60%	0.33	3.39	91.10%	33.40%	10.66%
MGTX	MEIRAGTX HOLDINGS PLC	$1.07B	283.90%	29.40%	27.73%	59.10%	0.84	3.76	97.90%	19.90%	23.60%
ASND	ASCENDIS PHARMA A	$14.98B	186.90%	44.00%	16.92%	30.30%	0.59	2.99	91.30%	70.80%	29.43%
IOVA	IOVANCE BIOTHERAPEUTICS INC	$6.55B	-40.50%	-31.60%	-36.33%	-73.20%	0.24	4.35	48.40%	-89.10%	-90.40%
HOWL	WEREWOLF THERAPEUTICS INC	$44.23M	-167.00%	-59.90%	-184.51%	-237.20%	0.48	2.91	100.00%	-164.80%	-143.14%
OABI	OMNIAB INC	$689.15M	-16.60%	-14.80%	-16.53%	-64.50%	0.12	4.80	98.30%	-115.10%	-118.86%
INSM	INSMED INC	$25.25B	-111.30%	-39.80%	-47.35%	-43.80%	1.78	3.72	83.50%	-76.90%	-69.25%
RIGL	RIGEL PHARMACEUTICALS INC	$913.26M	96.50%	72.30%	21.48%	29.00%	0.23	1.94	91.40%	116.30%	33.02%
GMAB	GENMAB A	$22.18B	13.60%	7.00%	11.70%	26.80%	1.10	2.46	93.00%	19.10%	32.22%
PRLD	PRELUDE THERAPEUTICS INC	$316.02M	-75.40%	-44.40%	-39.97%	-75.30%	0.42	4.07	100.00%	-269.70%	-269.75%
VRTX	VERTEX PHARMACEUTICALS INC	$133.51B	23.30%	16.90%	22.49%	31.00%	0.35	3.19	86.00%	35.00%	41.96%
SLN	SILENCE THERAPEUTICS PLC	$509.75M	N/A	-48.00%	-63.98%	-103.30%	-1.77	7.42	85.90%	-9,748.50%	-9,748.13%
LEGN	LEGEND BIOTECH CORP	$3.65B	-8.70%	-5.40%	-2.52%	-5.30%	0.42	3.04	56.60%	-7.20%	-2.67%
VIR	VIR BIOTECHNOLOGY INC	$1.80B	-30.00%	-23.60%	-22.44%	-31.30%	0.24	6.04	100.00%	-83.00%	-82.87%
ADMA	ADMA BIOLOGICS INC	$2.23B	39.60%	26.60%	37.03%	38.00%	0.68	6.97	64.70%	33.00%	43.98%
ANL	ADLAI NORTYE GROUP LTD	$1.01B	-20.20%	-14.10%	-9.53%	-39.60%	0.16	9.55	100.00%	-124.80%	-117.79%
SEPN	SEPTERNA INC	$1.83B	-6.30%	-4.10%	-4.70%	-6.10%	0.47	5.00	100.00%	-24.50%	-23.17%
ARMP	ARMATA PHARMACEUTICALS INC	$133.48M	N/A	-235.70%	106.59%	-69.30%	-1.39	0.11	N/A	N/A	N/A
ARVN	ARVINAS INC	$490.40M	1.90%	1.30%	1.70%	2.00%	0.20	7.91	97.20%	2.90%	3.19%
MDGL	MADRIGAL PHARMACEUTICALS INC	$11.77B	-56.60%	-25.50%	-33.73%	-29.30%	1.38	3.21	91.50%	-25.30%	-22.87%
FHTX	FOGHORN THERAPEUTICS INC	$209.04M	N/A	-31.20%	-42.26%	-68.00%	-3.51	3.36	100.00%	-175.80%	-175.78%
NRXS	NEURAXIS INC	$97.45M	-186.10%	-109.30%	-109.78%	579.80%	0.48	3.04	85.60%	-159.00%	-142.48%
SRZN	SURROZEN INC	$375.88M	N/A	-309.60%	-311.58%	-3,438.20%	-1.53	12.14	100.00%	-2,885.30%	-2,885.33%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$1.99B	-35.40%	-12.20%	-9.52%	-10.20%	1.21	4.05	34.90%	-37.10%	-25.79%
ALNY	ALNYLAM PHARMACEUTICALS INC	$34.00B	93.60%	15.80%	27.79%	22.30%	3.11	3.06	79.70%	16.80%	23.41%
URGN	UROGEN PHARMA LTD	$1.98B	N/A	-43.80%	-42.95%	-34.70%	-2.91	3.80	90.80%	-51.70%	-43.39%
FBIO	FORTRESS BIOTECH INC	$73.37M	95.70%	39.70%	49.51%	178.50%	0.67	3.96	65.60%	151.00%	184.19%
TVTX	TRAVERE THERAPEUTICS INC	$5.65B	-55.80%	-7.00%	-5.16%	-5.00%	31.60	4.05	98.60%	-7.40%	-5.64%
TARS	TARSUS PHARMACEUTICALS INC	$3.37B	-13.50%	-8.10%	-7.02%	-8.90%	0.76	3.20	93.30%	-7.70%	-5.04%
KRYS	KRYSTAL BIOTECH INC	$9.92B	19.30%	17.70%	16.50%	27.80%	0.10	8.32	94.60%	54.80%	51.45%
HYPD	HYPERION DEFI INC	$62.00M	5.20%	4.40%	26.24%	37.10%	0.11	2.34	78.40%	252.00%	2,016.22%
NVO	NOVO NORDISK A S	$169.94B	59.10%	21.10%	41.80%	49.50%	1.69	0.87	80.60%	35.30%	45.15%
AVXL	ANAVEX LIFE SCIENCES CORP	$218.76M	-12.80%	-11.70%	-11.56%	161.70%	0.07	15.62	N/A	N/A	N/A
KYMR	KYMERA THERAPEUTICS INC	$9.19B	-21.50%	-19.50%	-19.01%	-22.00%	0.09	10.34	100.00%	-285.30%	-285.02%
IMCR	IMMUNOCORE HOLDINGS PLC	$1.59B	-4.50%	-1.70%	1.07%	1.10%	1.67	4.47	98.90%	-4.20%	2.20%
NAGE	NIAGEN BIOSCIENCE INC	$233.42M	20.50%	15.00%	18.60%	88.80%	0.29	6.50	64.20%	12.40%	13.19%
ARDX	ARDELYX INC	$844.75M	-36.00%	-10.80%	-7.52%	-5.80%	2.87	3.34	94.40%	-12.40%	-7.40%
YARW	YARROW BIOSCIENCE INC	$64.58M	-70.20%	-64.60%	-84.78%	-478.90%	0.07	15.26	100.00%	-3,881.50%	-3,880.71%
INDP	INDAPTUS THERAPEUTICS INC	$379.74M	-302.80%	-203.50%	-135.62%	2,057.60%	0.05	19.48	N/A	N/A	N/A
MGNX	MACROGENICS INC	$240.15M	-31.30%	-5.40%	0.65%	0.60%	7.06	2.96	81.40%	-8.70%	0.91%
XNCR	XENCOR INC	$1.86B	-28.70%	-20.40%	-20.80%	-15.60%	0.44	6.39	100.00%	-155.60%	-127.44%
RYTM	RHYTHM PHARMACEUTICALS INC	$6.59B	-163.70%	-45.00%	-59.23%	-62.60%	2.14	3.45	89.00%	-87.60%	-77.44%
MRNA	MODERNA INC	$81.23B	-39.20%	-26.90%	-36.63%	-34.90%	0.62	2.30	23.40%	-141.40%	-138.55%
RGNX	REGENXBIO INC	$491.80M	-220.10%	-46.00%	-50.82%	-28.30%	4.39	2.86	86.40%	-112.60%	-88.54%
IVA	INVENTIVA SA	$635.75M	N/A	-192.20%	-79.70%	-87.70%	-9.75	3.16	100.00%	-4,468.10%	-1,730.94%
ELOX	ELOXX PHARMACEUTICALS INC	$62.24M	N/A	N/A	N/A	N/A	0.37	3.74	N/A	N/A	N/A
LKFT	LAKEFRONT BIOTHERAPEUTICS NV	$1.95B	16.90%	13.90%	14.43%	15.00%	0.04	30.48	97.90%	49.70%	47.97%
ACIU	AC IMMUNE SA	$264.53M	-99.20%	-28.10%	-85.61%	299.80%	3.28	0.93	100.00%	-246.50%	-245.27%
RANI	RANI THERAPEUTICS HOLDINGS INC	$111.52M	-129.90%	-66.40%	-57.71%	-98.80%	0.33	5.31	100.00%	-618.00%	-594.07%
STTK	SHATTUCK LABS INC	$656.38M	-43.60%	-40.90%	-24.69%	-85.30%	0.05	27.59	100.00%	-5,256.80%	-5,256.80%
IFRX	INFLARX NV	$21.37B	-58.00%	-46.60%	-26.62%	-170.10%	0.14	8.22	48,201.60%	387,532.10%	386,807.32%
SRPT	SAREPTA THERAPEUTICS INC	$1.97B	-10.00%	-4.10%	-4.87%	-4.30%	1.09	4.42	59.10%	-6.90%	-6.63%
CCCC	C4 THERAPEUTICS INC	$385.07M	-45.50%	-30.90%	-32.55%	-36.20%	0.45	5.45	100.00%	-289.40%	-289.09%
AXSM	AXSOME THERAPEUTICS INC	$9.75B	-255.60%	-27.00%	-61.82%	-127.70%	8.14	1.43	93.20%	-24.70%	-23.96%
ZYME	ZYMEWORKS INC	$1.93B	-72.10%	-37.10%	-40.81%	-39.70%	3.94	6.32	100.00%	-404.00%	-384.43%
ASMB	ASSEMBLY BIOSCIENCES INC	$478.07M	0.00%	0.00%	-0.01%	0.00%	0.08	13.99	N/A	N/A	N/A
PYPD	POLYPID LTD	$107.45M	-243.60%	-119.00%	-366.05%	-332.50%	1.83	1.35	N/A	N/A	N/A
ALGS	ALIGOS THERAPEUTICS INC	$70.19M	-160.70%	-92.30%	-199.07%	-228.40%	1.08	2.19	100.00%	-241.00%	-239.91%
XFOR	X4 PHARMACEUTICALS INC	$287.53M	-63.10%	-36.90%	-34.84%	-84.60%	0.63	11.30	81.50%	-568.80%	-513.82%
UTHR	UNITED THERAPEUTICS CORP	$20.65B	20.20%	18.00%	23.97%	31.10%	0.13	5.73	86.10%	41.60%	50.25%
INVA	INNOVIVA INC	$1.53B	30.00%	21.60%	26.43%	39.20%	0.38	16.01	72.20%	81.20%	99.46%
SCTX	SCRIBE THERAPEUTICS INC	$436.00M	N/A	N/A	N/A	N/A	-0.62	0.57	N/A	N/A	N/A
EDIT	EDITAS MEDICINE INC	$397.77M	-196.60%	-38.20%	-44.97%	-126.80%	1.26	3.19	100.00%	-157.30%	-161.60%
CMMB	CHEMOMAB THERAPEUTICS LTD	$12.13M	-70.40%	-62.60%	-86.97%	-184.70%	0.18	6.41	N/A	N/A	N/A
KURA	KURA ONCOLOGY INC	$961.22M	-207.20%	-45.20%	-62.88%	-62.00%	11.14	4.73	99.30%	-384.30%	-382.35%
CRSP	CRISPR THERAPEUTICS AG	$5.41B	-24.40%	-18.30%	-17.80%	-18.00%	0.52	17.85	100.00%	-3,368.70%	-3,346.08%
RARE	ULTRAGENYX PHARMACEUTICAL INC	$1.51B	N/A	-44.40%	-63.77%	-35.30%	-5.20	1.73	83.10%	-81.70%	-81.18%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Sep 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: B, Growth: C, Momentum: A, Sentiment: B, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 48, which is 24 points higher than the biotech industry average of 24.

PBYI passed 15 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 93.66% over the past year, overperforming other biotech stocks by 167 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -38.65% from Puma Biotechnology's current stock price of $9.78.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Precigen (NASDAQ:PGEN)

Precigen (NASDAQ:PGEN) is the #2 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Precigen (NASDAQ:PGEN) is: Value: C, Growth: A, Momentum: A, Sentiment: B, Safety: F, Financials: C, and AI: B.

Precigen (NASDAQ:PGEN) has a Due Diligence Score of 29, which is 5 points higher than the biotech industry average of 24.

PGEN passed 10 out of 33 due diligence checks and has average fundamentals. Precigen has seen its stock return 121.76% over the past year, overperforming other biotech stocks by 195 percentage points.

Precigen has an average 1 year price target of $13.67, an upside of 69.78% from Precigen's current stock price of $8.05.

Precigen stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Precigen, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Beone Medicines (NASDAQ:ONC)

Beone Medicines (NASDAQ:ONC) is the #3 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 28, which is 4 points higher than the biotech industry average of 24.

ONC passed 9 out of 33 due diligence checks and has average fundamentals. Beone Medicines has seen its stock return 9.75% over the past year, overperforming other biotech stocks by 83 percentage points.

Beone Medicines has an average 1 year price target of $418.55, an upside of 14.59% from Beone Medicines's current stock price of $365.27.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Beone Medicines, 81.82% have issued a Strong Buy rating, 18.18% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 5.33%, which is 3 percentage points higher than the biotech industry average of 2.12%.

Oramed Pharmaceuticals's dividend payout ratio of 5.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 4.84%, which is 3 percentage points higher than the biotech industry average of 2.12%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 46.1% indicates that its high dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.59%, which is -1 percentage points lower than the biotech industry average of 2.12%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 48.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.59% in the last day, and down -3.09% over the last week. Stablecoin Development was the among the top gainers in the biotechnology industry, gaining 108.28% yesterday.

Stablecoin Development shares are trading lower. The company announced it is aware of unusual trading activity and that there has been no material development in its business and affairs.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 42.15% in the past year. It has overperformed other stocks in the biotech industry by 115 percentage points.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 80.09% in the past year. It has overperformed other stocks in the biotech industry by 153 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Exelixis's stock has gained 44.56% in the past year. It has overperformed other stocks in the biotech industry by 118 percentage points.

Are biotech stocks a good buy now?

64.68% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 63.92% over the next year.

3.04% of biotech stocks have a Zen Rating of A (Strong Buy), 3.69% of biotech stocks are rated B (Buy), 44.9% are rated C (Hold), 36.88% are rated D (Sell), and 11.5% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 9.98x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Precigen (NASDAQ:PGEN)

3. Beone Medicines (NASDAQ:ONC)

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Precigen (NASDAQ:PGEN)

3. Beone Medicines (NASDAQ:ONC)

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.